Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “targeted”

263 pharma patents match "targeted" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 263
Index total 30,257
Page 5 / 11

Quick answer

This filtered view shows 263 pharmaceutical patents matching "targeted" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

263 results for “targeted” · 30,257 patents in full index Clear search

  1. US 10813909

    Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer

    The Regents of the University of California · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  2. US 10799461

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  3. US 10787499

    EpCAM targeted polypeptides, conjugates thereof, and methods of use thereof

    Regents of the University of Minnesota · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted

  4. US 10780058

    Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

    UNIVERSITY OF CONNECTICUT · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  5. US 10774122

    ERG targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  6. US 10759905

    Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biodegradable amphiphilic polymer in preparation of medicines for targeted therapy of lung cancer

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  7. US 10722525

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  8. US 10723803

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  9. US 10689717

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Therapeutics, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  10. US 10683272

    Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy

    Northwestern University · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  11. US 10676537

    Antibody targeted to tissue factor, preparation method therefor, and use thereof

    SHANGHAI MIRACOGEN INC. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  12. US 10675302

    Methods and compositions for targeted cleavage and recombination

    Sangamo Therapeutics, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  13. US 10675360

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  14. US 10669311

    Targeted delivery system and methods of use therefor

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

  15. US 10624849

    Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

    Northwestern University · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  16. US 10589997

    Discrete carbon nanotubes with targeted oxidation levels and stable gel formulations thereof

    MOLECULAR REBAR DESIGN, LLC · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  17. US 10583200

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  18. US 10543282

    Targeted peptide conjugates

    Marker Gene Technologies, Inc · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  19. US 10543481

    Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  20. US 10538570

    Targeted and modular exosome loading system

    Northwestern University · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  21. US 10537594

    Targeted transplantation of mitochondria to hepatocytes

    UNIVERSITY OF CONNECTICUT · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  22. US 10533056

    Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

    The Regents of the University of California · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

  23. US 10512691

    Systems and methods for targeted imaging and ablation of cardiac cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  24. US 10500229

    Targeted disruption of the MHC cell receptor

    Sangamo Therapeutics, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.